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Previous work has shown that the administration of as little as 1 gm. of 
sulfanilamide by mouth will completely eradicate both acute and chronic 
Plasmodium knowlesi  infections in rhesus monkeys (1).  The evidence of 
cure in these cases was:  (a) the permanent disappearance of parasites from 
the circulating blood; (b)  the failure to reproduce the infection in normal 
monkey  s by  the subinoculation of fresh blood from treated animals;  (c) 
the failure of treated monkeys to relapse following splenectomy; and (d) 
the successful reinfection of treated monkeys with the homologous  parasite. 
These findings were of special interest because untreated P. knowlesi malaria 
in monkeys is an infection that is almost invariably fatal, and in this respect 
it represents one of the most virulent malaria infections in either human 
beings or experimental animals. 
On the other hand, it has been the experience in this laboratory, as well 
as  of most  other workers,  that  sulfanilamide is  an  inferior  therapeutic 
agent  in  human malaria  (2-4).  The  drug has  also  failed  to  exert  any 
demonstrable influence, even with excessive doses, in canaries and chicks 
infected  with  Plasmodium  cathemerium  and  Plasmodium  lophurae, re- 
spectively (5). 
From the above mentioned findings it has been impossible to determine 
whether the activity of the drug varied from host to host, or whether it 
exerted its influence according to the species of plasmodium encountered. 
In order to  elucidate this point, additional studies on the action of sul- 
fanilamide on two plasmodial infections in a common host and on the effect 
of the drug on the metabolism of the parasites in vitro are here reported. 
Materials 
The host used was the rhesus monkey and the two species of parasites employed were 
Plasraodium knowlesi and Plasmodiura  inui (6). 
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The minimal infective dose for P. knowlesi is probably between one and ten parasites 
(7), and since there are no known insect vectors, infected blood was used for the inocu- 
lations.  Infections thus  established, unless interrupted early with antimalaria drugs, 
usually terminate in the death of the animal.  At the time of death 50 per cent or more 
of the red blood cells contain parasites, and there is a profound anemia. 
P. inui produces a  moderately severe infection following the injection of infected 
blood.  The parasite density at the height of the acute disease rarely exceeds 15 per cent 
of the normal red blood cells, and the acute attack usually subsides spontaneously into a 
chronic infection of indefinite duration. 
Mixed infections in monkeys to be used for treatment were produced by injecting 
viable P. knowlesi parasites into monkeys with chronic P. inui infections.  Mixed infec- 
tions in the controls were obtained in three ways: (a) the simultaneous injection of the 
two parasites, (b) superinfection of monkeys harboring P. inui infections with P. knowlesi 
parasites, and  (c)  superinfection of monkeys with chronic P. knowlesi infections with 
P. inui parasites. 
For  treatment  of  the  infected monkey  sulfanilamide  (para-amido-benzene sulfon- 
amide) was used, and the drug was always given by mouth in 1 gin. doses. 
Effect of Sulfanilamide on Simple P. knowlesi and P. inui Infections 
The dramatic manner  in which sulfanilamide effects a  cure of P. knowlesi 
infections in rhesus  monkeys  was  briefly summarized  above. 
Experiment/.--In order to test its effect against P. inui infections, monkeys 1, 2, and 
3 were injected and treated as shown in Table I.  Normal monkeys I and 2 were each 
inoculated intra-abdominally with 1 cc. of parasitized fresh blood.  Daily blood smear 
examinations revealed typical parasites in both monkeys by the 6th day.  Monkey 1 was 
then given three daily 1 gin. doses of sulfanilamide by mouth, while monkey 2 was kept 
as an untreated control.  During the first 48 hours of the period of treatment of monkey 
1  there was  a  slow increase in  the parasite count.  This  was followed by a  gradual 
decline to a  point  where plasmodia were absent from  the smears.  This picture per- 
sisted for approximately 2 weeks, when the parasites reappeared and steadily increased 
in number.  Monkey 2, the untreated control, had a  typical P. inui infection with the 
peak of the acute attack occurring on the 14th day.  6 weeks later, with both animals 
having identical parasite counts, monkeys 1 and 2  were each given three daily 1 gm. 
doses of sulfanilamide, this being the second course of treatment for monkey 1 and the 
first for monkey 2.  Again there was a  temporary reduction in circulating parasites in 
both monkeys, and smears were never negative for more than  a  few days at a  time. 
Monkey 3, used to repeat the experiment, had a chronic P. inui infection of 3 months' 
duration.  Its parasite count was  151 at the time when sulfanilamide was first given. 
Three daily 1 gm. doses produced no significant effect on the parasite density until 48 
hours after the third dose, when there was a diminution.  For 3 weeks the daily smears 
showed only an occasional parasite from time to time, and the count then returned to its 
pretreatment level. 
1 Parasite counts  given in  this paper refer to  the  number  of parasitized cells per 
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The outcome of these  results is seen in Table I.  It was observed that 
sulfanilamide  exerted  only  a  temporary  influence  on  P.  inui  in  rhesus 
monkeys,  regardless  of whether  they  were  treated  during  the  acute,  sub- 
acute,  or  chronic  stages of  the  disease.  This  was  true  even with  dosage 
in  excess  of  the  amount  found  necessary  to  eradicate  the  more  virulent 
P. knowlesi infections in the same species of monkey. 
Effect of Sulfanilamide in Mixed Infections 
To  obviate  the  influence  of  such  factors  as  individual  host  variation, 
differences  in  the  composition  of  the  drug  used  on  different  days,  and 
variations in the number and stage of parasites in the inoculum, an attempt 
was made to  demonstrate  the  selective activity of sulfanilamide  in mixed 
infections  in  the  same  experimental  animal.  One  should  thus  have  a 
better opportunity to observe the effects directly or indirectly on the para- 
site itself. 
Experiment 2.--Monkeys 4 and 5, shown in Table I, were suffering with chronic P- 
inui infection,  and each was superlnfected with 10,000 P. knowlesi parasites.  When the 
total parasite count of monkey 4 had increased from 16 to 160, and both species of para- 
site were identified in  the smears from morphological characteristics,  the animal was 
given a  1 gm. dose of sulfanilamide by mouth.  On the 3rd day following  treatment 
parasites  completely  disappeared  from  the  circulating  blood.  During  this  interval 
there was marked phagocytosis of malaria parasites by the circulating macrophages, as 
shown in Figs.  1 A and 1 B, some of which  contained as many as ten parasitized red 
cells.  Parasites did not reappear until 27 days after treatment, when they were identi- 
fied as  P. inui  morphologically.  This  fact  was  confirmed by subinoculation  into  a 
normal monkey, which  developed a  typical chronic P. inui infection from monkey 4. 
Monkey 5 remained untreated until the parasite count was 2,880 and the red count was 
2,100,000.  The  infection  was  predominantly  P.  knowlesi, although  there were  also 
present some of the P. inui variety.  At this point monkey 5 was so critically ill that it 
was transfused with 50 cc. of citrated normal monkey blood before being given 1 gm. of 
sulfanilamide by mouth.  On the following  day about half the cells  were parasitized 
(count 4,530), and a second transfusion of 40 cc. of normal blood was given along with 
2 gin. of the drug.  The parasite count dropped to 46 within 24 hours and was zero in 
48 hours.  During this period there was great activity of circulating macrophages in the 
phagocytosis of infected cells, as shown in Fig. 1A and 1 B.  Parasites outside the macro- 
phages appeared distorted and were poorly stained.  Thereafter there was an absence of 
parasites for 34 days, and when they reappeared they were identified  morphologically 
as P. inui.  This identification was confirmed, as with monkey 4, by subinoculation of 
blood into a normal monkey, and a resultant simple P. inui infection. 
The  results  seen  in  Table  I  showed  that  sulfanilamide,  either  directly 
or  indirectly,  had  the  ability  to  remove  a  virulent  plasmodial  infection 
and  was  practically  without  influence  on  the  milder P. inui  infection  in 
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TABLE  I 
Results of Sulfanilamide  Therapy  on Simple P. inui and Mixed P. knowlesi and P. inui 
Malaria Infections in Rhesus Monkeys and  Untreated Controls 
History of previous 
infection 
Kind  Dtiurna" 
Parasite used 
for 
inoculation 
Treatment with 
sulfanilamide 
Time  [ 
fter lastr  Parasite 
inocula- I  count at 
tion  at I begin- 
begin-  [ ning of 
ning of [ treat- 
treat-  ment 
ment 
Results 
Treated P. inui Infections 
Normal monkey 
Normal monkey 
P. inui 
days  [ 
--  I P" inui 
P. inui 
90 
days 
5 
49* 
49 
64 
++ 
12 
32 
Temporary suppression of infec- 
tion 
Temporary suppression  of infec- 
tion 
Temporary suppression of infec- 
tion 
Treated Mixed Infections 
P. inui 
P. inui 
110 
115 
P. knowlesi 
P. knowlesi 
14 
10 
160 
2,880 
Disappearance of P. knowlesi and 
temporary  suppression  of  P. 
•  inui 
Disappearance of P. knowlesi and 
temporary  suppression  of  P. 
inui 
Untreated Mixed Infections (Controls) 
6 
7 
8 
9 
10 
11 
P. inui 
P. inui 
P. knowlesi 
P. knowlesi 
Normal monke~ 
Normal monke 
68 
75 
100 
1.15 
P. knowlesi 
P. knowlesi 
Y. inui 
1'. inui 
P.  knowlesi 
and P. inui 
P.  knowlesi 
and P. inui 
Died llth day of P. knowlesi  in- 
fection 
Died 7th day of P. knowlesi  in- 
fection 
Typical  P. inui infection 
Typical P. inui infection 
Died  13th  day  of  P.  knowlesi 
infection 
Died  llth  day  of  P.  knowlesi 
infection 
* Same  monkey  treated  twice  with  sulfanilamide. 
+  indicates less than one parasite per I0,000 R.B.C. 
Effect  of Mixed  Plasmodial  Infection  in  Untreated  Monkeys 
In order to demonstrate  that  the drug was responsible for the disappear- 
ance of the more virulent parasite and not an antagonistic effect in mixed 
infections,  monkeys  were  infected  with  both  types of  parasites  and  their 
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Experiment  3.--The details and results of this experiment are summarized in Table I. 
Monkeys 6 and 7 with chronic P. inui infections of 68 and 75 days' duration were inocu- 
lated with  10,000 P. knowlesi parasites.  Both monkeys showed the presence of a mixed 
infection on the 5th day after inoculation  and died on the llth and 7th days, respec- 
tively.  Monkeys 8 and 9, with chronic P. knowlesi infections  established  by quinine 
some months previously,  were similarly infected with viable P. inui parasites.  In both 
instances the inoculated  monkeys experienced a typical mild P. inui infection.  Normal 
monkeys 10 and  11  were  each  inoculated  with  a  mixture  of  10,000,000 P. inui  and 
10,000 P. knowlesi parasites.  Both monkeys had mixed infections on the 7th day and 
died on the 13th and llth day, respectively,  the P. knowlesi parasites  having multiplied 
at their usual rate overshadowing  the mild infections. 
The results of these  controls,  summarized in Table I, show that in un- 
treated  mixed  infections  there  is  no  evidence  of  an  antagonistic  effect 
between  the  two plasmodia. 
The Effect of Sulfanilamide  on the Metabolism of the Parasites in  Vitro 
The difference in  the  reaction of plasmodial infections to  sulfanilamide 
in  a  common host was taken  as  evidence that the  drug acted directly on 
the  parasite  independently  of  the  host.  An  attempt  was  made  to  find 
whether the same difference would make itself manifest when sulfanilamide 
was added  to  the parasites  in vitro.  This was done by testing the  effect 
of  sulfanilamide  on  the  respiration  of  the  two  parasites  in  a  Warburg 
manometer.  ~ 
The parasites were obtained by bleeding monkeys  with well advanced infections.  In 
order to obtain P. inui infections  that were comparable  in intensity to P. knowlesi, it 
was necessary  to use  splenectomized  monkeys.  Heparinized  infected  blood was cen- 
trifuged and the brown parasite substance, which has a lower density, was removed from 
the top layer of the cellular material.  This was then resuspended in the same monkey's 
serum  in  the ratio of one part of parasites  to three parts  of serum.  The number of 
reticulocytes  and leukocytes  in the mixture  was below the concentration at which their 
metabolism  could interfere  with the results.  The system used was essentially  that of 
Christophers  and Fulton (8), with the exception that glucose was added to the medium. 
The sulfanilamide  was put in a side arm with Ringer solution at the end of a 30 minute 
control run.  To absorb  the C02 produced,  0.3 co. of 40 per cent KOH was put in the 
center cup.  Glycolysis was run in the same medium with NaHCO3 added. 
The  results  as  shown in  Text-fig.  1  are based on  100 million parasites, 
and  it  was  found  that  the  oxygen consumption for  P.  knowlesi  was  ap- 
2 The determinations  on the metabolic rate of the parasites  were done by Mr. Charles 
Kensler through the courtesy and in the laboratories  of Dr. C. P. Rhoads at The Rocke- 
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proximately six times greater than for the same number of P. inui parasites. 
Although the concentration of sulfanilamide (20 rag.  in  system) was ap- 
proximately one-third that  used to  cure a  monkey, there was a  marked 
paralyzing effect on the respiration of the parasite.  With 10 rag. of sulf- 
anilamide the effect was definite, but to a less degree.  There was no  ob- 
servable effect on the P. in~ui parasites by the same concentrations of the 
drug.  The  anaerobic  CO,. production  of  both  parasites  was  unaffected 
by sulfanilamide.  The R.Q. of P.  knowlesi,  confirming Christophers and 
Fulton (8), and of P. inui was'found to be slightly less than one. 
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TExT-FIG. 1.  Influence of sulfanilamide on the rate of  oxygen consumption of  P. 
knowlesi and P. inui parasitized red cells in vitro. 
Effect of Sulfanilamide against P. knowlesi in Other Hosts 
The next point taken up was whether sulfanilamide is effective against 
the  parasites  regardless  of  the  host.  Human  volunteers  with  general 
paresis  and  resistant  to  therapeutic vivax  malaria  were inoculated with 
P. knowlesi  infected blood and subsequently treated with the drug.  Al- 
though  the  infections  were  mild,  they  disappeared  promptly  after  the 
administration of sulfanilamide, but  the  extremely variable  character of 
untreated P. knowlesi  infections in man does not allow for more than in- 
ferential evidence of the action of the drug. 
Two  cynomolgos monkeys were  inoculated  with  blood  infected  with 
P. knowlesi,  and in this instance also the resultant infection in untreated 
controls was  so  mild  and  transitory that  no  definite conclusions  can be 
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DISCUSSION 
The highly selective action of sulfanilamide against two species of plas- 
modia in the same experimental animal and the parallel effect when tested 
on the metabolism of the parasites in vitro offer several points for discus- 
sion.  They indicate the necessity of taking into consideration the metab- 
olism  of parasites  themselves as  a  factor when  testing  the  effectiveness 
of any antimalaria  drug.  No  therapeutic agent should be  discarded on 
the basis  of a  negative result against  one plasmodium, nor  can such an 
agent be proclaimed as a  universal remedy, regardless of its effectiveness 
against  one  type  of  infection. 
No attempt was made in this study to learn why sulfanilamide has an 
inhibitory action upon one malaria parasite and not upon another closely 
related  one.  Results  obtained  from  numerous  studies  of  its  action  on 
bacteria suggest that the effect of the drug is probably an oxidation process 
resulting  either  in  partial  or  complete interference with  the metabolism 
of the parasite.  The results of this study confirm the suggestion made by 
Fulton and Christophers (9)  that the influence of an antimalaria drug on 
the metabolism of a  malaria parasite in vitro  gives the most direct indica- 
tion regarding its efficiency as a  therapeutic agent. 
SUMMARY 
It  was  found  that  with  mixed malaria  infections in  the  same  experi- 
mental  animal  sulfanilamide eradicates a  virulent  P.  knowlesi  infection, 
leaving the animal with a milder chronic P. inui infection.  Determinations 
of the metabolic activity of the two parasites in vitro showed that P. knowlesi 
consumed approximately six times more oxygen than P. inui.  The addi- 
tion of sulfanilamide in  concentrations less than that necessary to  effect 
a  cure almost completely inhibited the respiration of P. knowlesi parasites 
in vitro, while the same concentrations of the drug against the same number 
of P.  inui parasites had no apparent effect. 
BIBLIOGRAPHY 
1.  Coggeshall, L. T., Am. J. Trop. Med., 1938, 18, 715. 
2.  Read, H., and Pino, J. O., Arch. Schiffs.-  u Tropen-Hyg.,  1938, 42,  132. 
3.  Niven, J. C., Bull. Inst. Med. Research, Federation Malay States,  1938, 4, 1. 
4.  Faget, G. H., Palmer, M. R., and Sherwood, R. 0., Pub. Health  Rep., U. S. P. H. S., 
1938, 58, 1364. 
5.  Coggeshall, L. T., Proc. Soc. Exp. Biol.  and Med., 1938, 38, 768. 
6.  Coggeshall, L. T., and Kumm, H. W., J. Exp. IVied., 1937, 66, 177. 
7.  Coggeshall, L. T., and Eaton, M. D., J. Exp. Ivied., 1938, 68~ 29. 
8.  Christophers,  Sir S. R., and Fulton, J. D., Ann. Trop. ]fled. and Parasitol.,  1938, 3% 43. 
9.  Fulton, J. D., and Christophers,  Sir S. R., Ann. Trop. Med. and Parasitol., 1938, 39., 77. 2O  SELECTIVE  ACTION  OF  SULFANILAMIDE IN  MALARIA 
EXPLANATION OF PLATE  1 
FIc.  1 A. High percentage of parasitized red blood cells with untreated, mixed P. 
knowlesi and P. inui infections. 
FIc. 1 B.  Macrophages with phagocyted infected red cells in blood from same monkey 
48 hours after sulfanilamide therapy. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE VOL. 71  PLATE  1 
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